Tri Locum Partners LP
Source: SEC Form 13F · as of Mar 2026Tri Locum Partners LP holds 7 biotech & pharma companies tracked by BioSniper, totaling $145.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
7
Total value held
$145.2M
BioSniper AIPage context preserved
Prepared research question
What matters most for Nuvalent, Inc. (NUVL)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| NUVLNuvalent, Inc. | 308,506 | $31.6M |
| TEVATeva Pharmaceutical Industries Limited | 1,021,008 | $30.8M |
| JAZZJazz Pharmaceuticals plc | 158,663 | $30.0M |
| ARGXARGENX SE | 31,635 | $23.1M |
| DNTHDianthus Therapeutics, Inc. /DE/ | 145,543 | $12.2M |
| AXSMAxsome Therapeutics, Inc. | 62,116 | $10.5M |
| DFTXDefinium Therapeutics Inc. | 369,588 | $7.0M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.